ANIMAL MODEL FOR NEPHROPATHY AND AGENTS FOR TREATING THE SAME
Abstract:
A non-human transgenic animal expressing ApoL1 is provided as well as a method for generating the same. Also provided is a method for identifying an agent capable of reducing the progression of an ApoL1 mediated nephropathy. Furthermore, an isolated antibody is provided which binds to the human variants of ApoL1.
Information query
Patent Agency Ranking
0/0